Trial Profile
A postmarketing retrospective study of topiramate monotherapy to evaluate fetal or neonatal outcomes in women with and without epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 03 Dec 2015 New trial record